Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Samsung Biologics Lands Major European Deals | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Samsung Biologics Lands Major European Deals

The latest agreements bring up the company's cumulative contract value for this year to more than $4 billion.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Samsung Biologics, a global contract development and manufacturing organization (CDMO), has announced a series of manufacturing deals with a Europe-based pharmaceutical company.
 
The disclosed deals, worth over $668 million combined, will run through December 2031. The latest agreements bring up the company’s cumulative contract value for this year to more than $4 billion.
 
“We are delighted to expand our partnership with the European pharmaceutical company toward our shared commitment to delivering high-quality biopharmaceuticals to patients,” said John Rim, President and CEO of Samsung Biologics. “As we further expand strategic collaboration with clients worldwide, we also make continued investments in our capabilities and manufacturing technologies. Our goal is to provide the highest-quality services at every stage and deepen our trusted partnerships.”
 
The company has secured several significant deals this year, solidifying its customer base across the U.S., Asia, and Europe. It now claims to be partnered with 17 of the world’s top 20 pharmaceutical companies.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters